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The Results of the PARAMEDIC 2 Clinical Trial 
John Long  
Patient/Public Involvement Consultant on Trial at the Clinical Trials Unit of 
the Medical School of the University of Warwick 
johnpatlong@aol.com  
Background 
Concern about adrenaline (known as epinephrine in the USA) as a treatment for 
out-of-hospital cardiac arrest led to the International Liaison Committee on 
Resuscitation and other international organisations to call for a placebo- 
controlled trial to see if adrenaline is safe and effective to use as a treatment. 
Trial 
A randomised double blind trial involving 8014 out-of-hospital cardiac arrest 
patients was run over four years in five National Health Ambulance Trust areas 
in the United Kingdom with paramedics administering adrenaline or saline 
placebo along with standard CPR techniques. The trial was co-ordinated by the 
Clinical Trials Unit of the Medical School of the University of Warwick.   
Professor Gavin Perkins was the Chief Investigator. The primary outcome was 
the rate of survival to 30 days post-arrest.  A secondary outcome included the 
rate of survival until hospital discharge with favourable neurologic outcome (on 
the modified Rankin scale) 
Results 
At 30 days 3.2% in the adrenaline group and 2.4% in the placebo group were 
alive.  There was no significant difference in the proportion of patients who 
survived with favourable outcomes in each group.  At the time of hospital 
discharge, however, severe neurologic impairment had occurred in 31% of the 
patients in the adrenaline group as against only 17.8% in the placebo group. 
Conclusion 
In adults with out-of-hospital cardiac arrest whilst the use of adrenaline resulted 
in a slightly higher rate of 30-day survival those receiving such treatment 
resulted in nearly twice the rate of survivors with severe neurologic impairment. 
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